In allergen-driven models of atopic dermatitis, subcutaneous (SQ) administration of ‘1104 demonstrated comparable performance to intravenous administration (IV) In multiple preclinical models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback